www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line

Catalogue number:
Supplier:
Size:
2 vials
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£16872.00 Shipping is calculated in checkout
Alternative Names:

Beta-2-microglobulin, B2M, CDABP0092, HDCMA22P

image 0
image 1
Product Description:

This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells to generate the TCR Knockout NFAT Luciferase Reporter Jurkat cell Line (BPS Bioscience #78556). These TCR knockout cells were used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing.  Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity.  This product is for research use only and is subject to a Limited Use License. For your order to be processed, you will be required to complete a Limited Use License Agreement form at: https://bpsbioscience.com/license/agreement/form, ensuring you state your Purchase Order number when asked for Sales Order/Quote #. Further information can be found at: https://bpsbioscience.com/license.

TCR/B2M Knockout NFAT Luciferase Reporte
TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line